Meta Faces Calls For Federal Scrutiny After Report Claims Revenue From Fraudulent Ads A recent Reuters report claimed that Meta earned a substantial portion of its revenue from fraudulent or banned ads.
Could Buying the iShares Russell 2000 Growth ETF (IWO) Today Set You Up for Life? It's a good option if you're looking to add small-cap stocks to your portfolio. But it's not your only good option.
Why AI Stalwart Nvidia’s Stock Is Rising Premarket Nvidia retail traders brace for a strong run in the stock heading into year-end, a period that coincides with one of the market's seasonally strongest periods.
If I Could Choose Only 1 ETF to Buy and Hold Forever, This Would Be It If a market downturn is looming, this is the ETF I'll be loading up on for the future.
Alphabet: The ‘Best AI’ Play Right Now? Retail Bulls Hype Up GOOGL As Shares Push For A Clean Break Above $300 Alphabet has bulldozed its way to be the best “Magnificent Seven” stock this year as the company taps into its multiple growth levers.
1 Top Vanguard Fund That Can Turn $440 Per Month Into $1 Million in 30 Years The Vanguard Total Stock Market Index Fund ETF performed similarly to the S&P 500 over the past decade.
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software The company said it will work with the agency to reach a resolution and expressed confidence in its clinical data.
Gene Munster Says Nvidia’s Optimistic Guidance Signals AI Boom Is Far From Over Gene Munster stated that Nvidia’s outlook underscores how early we still are in the AI buildout.
TELO Stock Jumps Pre-market After Early Study Results Show Leukemia Cell Death HL60 leukemia cells were treated with Telomir-1, which produced a clear, dose-dependent reduction in viable leukemia cells, indicating strong activity in this aggressive human model, the company said.
Amazon’s Massive Layoffs Hit Mid-Level Software Engineers The Most: Report Documents submitted to government agencies in New York, California, New Jersey, and Washington reveal a huge portion of job cuts targeted engineers.
Applied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Options The board is considering mergers, acquisitions, partnerships, joint ventures, licensing arrangements or other strategic transactions, the company said.
